You have 9 free searches left this month | for more free features.

MDX010

Showing 176 - 196 of 196

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer, Tumor Metastasis Trial in United States (MDX-010)

Completed
  • Prostate Cancer
  • Neoplasm Metastasis
  • Los Angeles, California
  • +13 more
Aug 14, 2014

Advanced Melanoma Trial in United States (Ipilimumab)

Completed
  • Advanced Melanoma
  • Ipilimumab
  • Los Angeles, California
  • +6 more
May 20, 2014

Melanoma Trial in Worldwide (Ipilimumab, Placebo, Dacarbazine)

Completed
  • Melanoma
  • Anaheim, California
  • +126 more
Oct 24, 2014

Advanced Melanoma Trial in United States (Ipilimumab, Carboplatin, Paclitaxel)

Completed
  • Advanced Melanoma
  • Los Angeles, California
  • +3 more
Dec 31, 2013

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Ocular Melanoma Trial in Germany (Ipilimumab)

Completed
  • Ocular Melanoma
  • Erlangen, Bayern, Germany
  • +24 more
Jun 20, 2014

Melanoma (Skin) Trial (gp100:209-217(210M) peptide vaccine, gp100:280-288(288V) peptide vaccine, incomplete Freund's adjuvant)

Withdrawn
  • Melanoma (Skin)
  • gp100:209-217(210M) peptide vaccine
  • +3 more
  • (no location specified)
May 14, 2013

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +61 more
  • La Jolla, California
  • +4 more
Mar 26, 2013

Melanoma Trial in Brazil (Ipilimumab)

No longer available
  • Melanoma
  • Salvador, Bahia, Brazil
  • +8 more
May 30, 2013

Melanoma (Skin) Trial run by the CC (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)

Completed
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 21, 2012

Breast Cancer, Adenocarcinoma Trial in United States (MDX-010)

Completed
  • Breast Cancer
  • Adenocarcinoma
  • San Diego, California
  • +13 more
Apr 26, 2012

Kidney Cancer Trial run by the CC (ipilimumab)

Completed
  • Kidney Cancer
  • ipilimumab
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Mar 14, 2012

Melanoma Trial (Ipilimumab, Interferon, Interleukin-2 (Aldesleukin))

Withdrawn
  • Melanoma
  • (no location specified)
Jan 25, 2012

Melanoma Trial in United States (AntiCD137, Ipilimumab)

Withdrawn
  • Melanoma
  • Los Angeles, California
  • +6 more
Nov 18, 2011

Prostate Cancer Trial in United States (MDX-010 / MDX-010 + Docetaxel)

Completed
  • Prostate Cancer
  • MDX-010 / MDX-010 + Docetaxel
  • Tucson, Arizona
  • +10 more
Jun 23, 2011

Melanoma Trial in United States (MDX-010 (CTLA-4))

Completed
  • Melanoma
  • MDX-010 (CTLA-4)
  • Tucson, Arizona
  • +8 more
Jan 20, 2011

Melanoma, Metastases Trial in Worldwide (MDX-010 (anti-CTLA4) mAb, MDX-1379 (gp100) Melanoma Peptide Vaccine)

Completed
  • Melanoma
  • Metastases
  • MDX-010 (anti-CTLA4) monoclonal antibody
  • MDX-1379 (gp100) Melanoma Peptide Vaccine
  • Tucson, Arizona
  • +208 more
Jun 29, 2011

Malignant Melanoma Trial in United States (MDX-010)

Completed
  • Malignant Melanoma
  • MDX-010
  • Tucson, Arizona
  • +3 more
Apr 23, 2010

Long-term Data Collection for Subjects in MDX-010 Studies

Completed
  • Metastatic Melanoma
    • Tuscon, Arizona
    • +10 more
    Apr 23, 2010

    Melanoma Trial in Worldwide (ipilimumab (MDX-010, BMS-734016), Ipilimumab)

    Completed
    • Melanoma
    • Tucson, Arizona
    • +61 more
    Feb 27, 2010